GSM Fund is a principal investment firm that provides its users with an equity enhancement facility.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Oct 1, 2015
Elcelyx Therapeutics
|
Series E | $40M | Biotechnology | — |
Feb 20, 2014
Elcelyx Therapeutics
|
Series C | $24.72M | Biotechnology | — |
Jan 31, 2000
Webraska
|
Series A | €10M | Information Services | — |